RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:439218

KCNQ2-related developmental and epileptic encephalopathy

medium confidenceDisorder

Also known as: KCNQ2-DEE

Publications

164

74.2th percentile

Trials

2

Interventional, condition-specific

Researchers

1,371

Distinct authors in sample

Gene link

KCNQ2

Definitive

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

KCNQ2-related epileptic is a severe form of that usually manifests in newborns during the first week of life with (that affect alternatively both sides of the body), often accompanied by clonic jerking or more complex motor behavior, as well as signs of such as diffuse , limb spasticity, lack of visual fixation and tracking and mild to moderate intellectual deficiency. The severity can range from controlled to intractable and mild/moderate to severe .

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (6)

DEE7 · EIEE7 · KCNQ2-NEE · developmental and epileptic encephalopathy 7 · epileptic encephalopathy, early infantile, 7 · epileptic encephalopathy, early infantile, type 7

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedPresent

    Definitive — KCNQ2

  2. LiteraturePresent

    164 matched papers (152 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    2 matched on ClinicalTrials.gov

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (KCNQ2).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

164

164 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

164 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

152 in the last 10 years · medium confidence · 74.2th percentile (publications denominator)

Phrase hits: 164 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,371

Distinct author names in 164 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Taglialatela M13 papers · 2026

    Department of Neuroscience, University of Naples Federico II Naples, Italy ; Department of Medicine and Health Sciences, University of Molise Campobasso, Italy.

    Papers in Europe PMC
  2. 02
    Weckhuysen S11 papers · 2026

    Neurogenetics GroupDepartment of Molecular GeneticsVIBAntwerpBelgium; Laboratory of NeurogeneticsInstitute Born-BungeUniversity of AntwerpAntwerpBelgium.

    Papers in Europe PMC
  3. 03
    Miceli F10 papers · 2026

    Department of Neuroscience, University of Naples Federico II Naples, Italy.

    Papers in Europe PMC
  4. 04
    Cooper EC9 papers · 2026

    Department of Neurology, Neuroscience and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

    Papers in Europe PMC
  5. 05
    George AL Jr8 papers · 2026

    Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

    Papers in Europe PMC
  6. 06
    Soldovieri MV8 papers · 2024

    Department of Medicine and Health Sciences, University of Molise Campobasso, Italy.

    Papers in Europe PMC
  7. 07
    Berg AT7 papers · 2026

    Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Electronic address: a-berg@norwestern.edu.

    Papers in Europe PMC
  8. 08
    Lesca G7 papers · 2026

    Department of Medical Genetics, Lyon University Hospital, 69677 Lyon, France.

    Papers in Europe PMC
  9. 09
    Milh M7 papers · 2026

    INSERM, Marseille Medical Genetics, U1251, Aix-Marseille Université, 13385 Marseille, France.

    Papers in Europe PMC
  10. 10
    Villard L7 papers · 2026

    Inserm, UMR_S 910, Génétique Médicale et Génomique Fonctionnelle, Marseille, France.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

2

interventional trials for this specific condition

2 interventional trials matched this specific condition name; none in our sample are currently recruiting. 13 trials are registered for developmental and epileptic encephalopathy, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

2 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 82.4th percentile).

medium confidence · 82.4th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

2 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Broader category: developmental and epileptic encephalopathy

13

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Observational and natural-history studies

2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

None of the matched observational studies is currently listed as recruiting.

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"KCNQ2-related developmental and epileptic encephalopathy" OR "KCNQ2-DEE" OR "EIEE7" OR "KCNQ2-NEE" OR "developmental and epileptic encephalopathy 7" OR "epileptic encephalopathy, early infantile, 7" OR "epileptic encephalopathy, early infantile, type 7"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"KCNQ2-related developmental and epileptic encephalopathy" OR "KCNQ2-DEE" OR "EIEE7" OR "KCNQ2-NEE" OR "developmental and epileptic encephalopathy 7" OR "epileptic encephalopathy, early infantile, 7" OR "epileptic encephalopathy, early infantile, type 7" OR "KCNQ2"

Recall-expansion terms: KCNQ2

Interventional trials matched via: phrase, recall-expansion (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 2 interventional · 2 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"developmental and epileptic encephalopathy"

Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: DEE7

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T16:17:43.387Z